HIV Infections: all 4,342 studies
Page 25 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Multi-vitamins, HAART and HIV/AIDS in UgandaCompletedNCT01228578Phase 3
- Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)CompletedNCT01227590Phase 1
- Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed InfantsCompletedNCT01222130
- Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected AdultsCompletedNCT01215149Phase 1
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedNCT01214993Phase 1
- Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected PatientsStatus unknownNCT01213186Phase 2
- Chinese Network of Pediatric Antiretroviral TherapyCompletedNCT01210924
- A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435CompletedNCT01209117Phase 1
- GSK1349572 Drug Interaction Study With Fosamprenavir/RitonavirCompletedNCT01209065Phase 1
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot StudyCompletedNCT01207986Not applicable
- The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model SystemCompletedNCT01206933
- ZIAGEN® Post-marketing SurveillanceCompletedNCT01205243
- Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young AdultsCompletedNCT01203332
- Affect Management for Early AdolescentsCompletedNCT01197404Phase 2
- Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-InfectionCompletedNCT01197027Phase 3
- KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)CompletedNCT01196195Phase 2/3
- A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.TerminatedNCT01195974Phase 1
- Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?CompletedNCT01195077Phase 1/2
- PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing RegimenCompletedNCT01190293Phase 4
- Reducing HIV in AdolescentsCompletedNCT01187979Phase 2
- The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine ResistanceCompletedNCT01187719Phase 2
- Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male CircumcisionCompletedNCT01186575Not applicable
- Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected PopulationCompletedNCT01180075
- Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?CompletedNCT01176409Phase 3
- A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear CellsWithdrawnNCT01173510Phase 4
- HIV/AIDS, Severe Mental Illness and HomelessnessCompletedNCT01172704Phase 2
- Impact of Nutrition Intervention on HIV/AIDS Infected PatientsCompletedNCT01171495Phase 3
- Computer-Assisted Tailored Cue-card Health [CATCH] StudyCompletedNCT01170741Phase 1
- Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease InhibitorCompletedNCT01166477Phase 4
- Pilot Study of Raltegravir Lipodystrophy IISPStatus unknownNCT01164605Not applicable
- Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)CompletedNCT01164462Not applicable
- Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine UsersCompletedNCT01161485Not applicable
- Antigenic Competition in HIV Preventive VaccinesCompletedNCT01159990Phase 1
- Peer Leaders as HIV Risk Reduction Change Agents Among Injection Drug Users (IDUs) in UkraineCompletedNCT01159704Not applicable
- Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)CompletedNCT01159223Phase 4
- Pharmacokinetics of Low Dose RaltegravirCompletedNCT01159132Phase 2
- Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIVStatus unknownNCT01157442Not applicable
- Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected AdultsCompletedNCT01155037Phase 2
- Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention StrategiesCompletedNCT01152918Not applicable
- Selective Exposure in HIV PreventionCompletedNCT01152281Phase 2
- A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural SettingsCompletedNCT01150370Not applicable
- A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal RingCompletedNCT01144676Phase 1
- Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in UgandaCompletedNCT01144234Not applicable
- The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected PatientsCompletedNCT01141777Not applicable
- Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaCompletedNCT01140633
- Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)CompletedNCT01138267
- Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) ValidationCompletedNCT01138241
- A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.CompletedNCT01138072Phase 1
- Tenofovir Gel in Pregnancy and LactationCompletedNCT01136759Phase 1
- Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of AgeCompletedNCT01127204Phase 2/3
- A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected PeopleTerminatedNCT01123915Phase 1
- Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once DailyCompletedNCT01121809Phase 4
- Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)CompletedNCT01119729
- The First Failure StudyTerminatedNCT01118871Phase 4
- Evaluation of a Computer-Based System Using Cell Phones for HIV People in PeruCompletedNCT01118767Not applicable
- A New Telemedicine Approach for Chronic HIV/AIDS Patient Home CareCompletedNCT01117675Not applicable
- Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV InfectionCompletedNCT01114425Phase 3
- Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women PrisonersCompletedNCT01111721Not applicable
- Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in UgandaCompletedNCT01109342
- PK of Tenofovir, Emtricitabine and Efavirenz in Healthy VolunteersCompletedNCT01108926Phase 1
- Injecting Drug Use Community Intervention TrialStatus unknownNCT01108614Phase 3
- A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)CompletedNCT01106638Phase 3
- Test of an Intervention to Improve HIV CareCompletedNCT01103856Not applicable
- Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected AdultsCompletedNCT01103687Phase 1
- Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)CompletedNCT01103596
- A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult SubjectsCompletedNCT01101893Phase 1
- GSK1349572 Drug Interaction Study With EfavirenzCompletedNCT01098526Phase 1
- GSK1349572 Relative Bioavailability StudyCompletedNCT01098513Phase 1
- HIV Fat Redistribution and the Evaluation of Brown FatCompletedNCT01098045
- Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected AdultsCompletedNCT01095224Phase 1
- TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected PatientsCompletedNCT01090648Phase 1
- Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With MenCompletedNCT01087840Phase 4
- Safety of Cotrimoxazole in HIV- and HAART-exposed InfantsCompletedNCT01086878Phase 4
- Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV DetectionCompletedNCT01084954
- A Computer-Based Parent/Adolescent HIV Communication Intervention for LatinosCompletedNCT01084421Not applicable
- Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult ParticipantsCompletedNCT01082692Phase 1
- Polyacrylamide Hydrogel Injection in HIV-related LipoatrophyCompletedNCT01077765Phase 3
- PENTA Fosamprenavir StudyCompletedNCT01077635
- Fractures Stratified by HIV and Antiretroviral Therapy (ART) StatusCompletedNCT01077557
- Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail StudyCompletedNCT01073761Phase 1
- Improving Sleep and Quality of Life in Adults With HIV DiseaseCompletedNCT01073423Not applicable
- A Safety Study of Dapivirine Vaginal Ring in AfricaCompletedNCT01071174Phase 1/2
- HIV Vaccine Study in HIV Positive PatientsCompletedNCT01071031Phase 1
- Community-based Accompaniment With Supervised Antiretrovirals in Lima, PeruCompletedNCT01070017Phase 3
- Safety and Efficacy Study of AGS-004 During Analytical Treatment InterruptionCompletedNCT01069809Phase 2
- Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy VolunteersCompletedNCT01068925Phase 1
- Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected PatientsStatus unknownNCT01067417Phase 2
- Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve SubjectsCompletedNCT01066962Phase 3
- Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and BreastfeedingCompletedNCT01066858
- Stocrin Re-examination Study (0831-028)CompletedNCT01065792
- Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in DenmarkCompletedNCT01061957
- Adherence Intervention for People With Low-literacyCompletedNCT01061762Phase 2
- IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and AdolescentsCompletedNCT01061164
- HIV Prevention Intervention for People Living With HIV/AIDSCompletedNCT01061021Phase 2
- Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short TermCompletedNCT01060618Phase 2/3
- An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative PersonsWithdrawnNCT01059084Not applicable
- The Impact of Short Message Services (SMS) on ARV Adherence in Western KenyaCompletedNCT01058694Not applicable
- Effect Of Maraviroc On The Pharmacokinetics Of DigoxinCompletedNCT01056874Phase 1
- Investigator-Sponsored Protocol - Continued Use of IbalizumabCompletedNCT01056393Phase 2